BioMed Research International / 2017 / Article / Tab 1

Review Article

Lurasidone in the Treatment of Bipolar Depression: Systematic Review of Systematic Reviews

Table 1

Search strategy across alternative databases (queries run on October 14, 2016).

SetMedline (via PubMed)

1#1 Lurasidone Hydrochloride [MeSH Major Topic]
2#2 review[Publication Type] OR meta-analysis[Publication Type]

3Sets were combined with “OR”

4Bipolar disorder
5Depression

6Sets 1–5 were combined with “OR” & “AND”

Most permissive (generic PubMed - no MeSH headings)((Lurasidone) AND Bipolar) AND review[Publication Type]

Embase

Most permissive#1 “lurasidone”/exp OR lurasidone AND “bipolar depression”:ab,ti AND review:it

Scopus

Most permissive(TITLE-ABS-KEY (lurasidone) AND TITLE-ABS-KEY (bipolar disorder)) AND DOCTYPE (re)

Cochrane Library

Most permissive“Lurasidone in Title, Abstract, Keywords and ‘bipolar disorder’ in Title, Abstract, Keywords and ‘review’ in Publication Type ”

Note. Words written in italic were used as MeSH headings; the others were used as free text.
Proposed entry terms, then accounted as free text integrations:
Hydrochloride, Lurasidone
Lurasidone HCl
HCl, Lurasidone
SM 13496
13496, SM
SM13496
SM-13496
SM-13,496
SM 13,496
SM13,496
Lurasidone
N-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinylmethyl)-1-cyclohexylmethyl)-2,3 bicyclo(2.2.1)heptanedicarboximide
Latuda.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.